(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS MONOCLONAIS HUMANIZADOS QUE VISAM VE-PTP (HPTP-SS)

ArquivadaInvention PatentPCT · US2017042855

Application data

Number

112019001206

Type

Invention Patent

Filing

07/19/2017

Publication

06/25/2019

PCT

US2017042855

Progress at the INPI

  1. Filing07/19/17
  2. Publication06/25/19
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 07/19/2017 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/05/2021. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AERPIO THERAPEUTICS INC.

US

See this company's full portfolio

Inventors

K. P. (pessoa física)

US

M. F. (pessoa física)

US

Technical data

Priority claims

US

62/364,381 · 07/20/2016

US

62/377,072 · 08/19/2016

Abstract

A revelação proporciona composições e métodos para o tratamento de condições oculares associadas a angiogênese compreendendo a administração de um anticorpo que visa um inibidor da tirosina fosfatase num indivíduo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Adição na publicação

#15.35

10/05/2021

RPI 2648

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

03/09/2021

RPI 2618

Arquivamento - Art. 33 da LPI

#11.1

12/22/2020

RPI 2607

Notificação de entrada na fase nacional - PCT

#1.3

06/25/2019

RPI 2529

Alteração de dados cadastrais

#1.1

01/29/2019

RPI 2508

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.